In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis.
In vivo brain microdialysis was used to characterize the effects of some dopamine uptake inhibitors on the extracellular concentrations of dopamine (DA) and its metabolites dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the striata of awake, freely moving rats. d-Amphetamine, GBR 12909, cocaine, nomifensine, methylphenidate, bupropion, and benztropine were administered directly to the striatum via the perfusion fluid in increasing concentrations (1-1,000 microM). All drugs increased extracellular DA in a dose-dependent manner; however, only d-amphetamine produced dose-dependent decreases in DOPAC and HVA concentrations. The shapes of the dose-response functions differed considerably between the drugs. At 100 and 1000 microM d-amphetamine had biphasic effects (an increase followed by a decrease) on dialysate DA concentrations. GBR 12909, methylphenidate, and benztropine also had biphasic effects when applied at the 1,000 microM concentration. In contrast, cocaine, nomifensine, and bupropion produced relatively monophasic increases in extracellular DA. Tetrodotoxin (TTX), which prevents action potentials by blocking voltage-dependent Na+ channels, did not prevent d-amphetamine induced increases in extracellular DA, but blocked completely the effects of cocaine, nomifensine, bupropion, and methylphenidate. While low doses (10 microM) of GBR 12909 and benztropine were highly sensitive to TTX, the toxin was only partially effective against higher doses of the compounds.(ABSTRACT TRUNCATED AT 250 WORDS)
Nomikos
G G
GG
Department of Psychiatry, University of British Columbia, Vancouver.
Damsma
G
G
Wenkstern
D
D
Fibiger
H C
HC
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D003956:Dialysis / Q000379:methods; D004298:Dopamine / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008297:Male; D014179:Neurotransmitter Uptake Inhibitors / Q000494:pharmacology*; D011619:Psychotropic Drugs / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D013779:Tetrodotoxin / Q000494:pharmacology
D014179:Neurotransmitter Uptake Inhibitors; D011619:Psychotropic Drugs; D015102:3,4-Dihydroxyphenylacetic Acid; D013779:Tetrodotoxin; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D006719:Homovanillic Acid